Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This selective action means it primarily targets growth hormone release, leaving other hormones like cortisol, prolactin, and aldosterone largely unaffected
However, because of potential side effects like skin rashes or the reversion effect where results fade after stopping treatment, you must not attempt to self-medicate
This ensures safe, coordinated care
GLP-1RA Liraglutide Semaglutide Efpeglenatide Glucose lowering effect CV system protection effect Kidney protection effect Nonalcoholic fatty liver disease GIP/GLP1 receptor coagonists: tirzepatide Amylin/GLP1 receptor coagonists: CagriSema (cagrilintide+semaglutide) Glucagon/GLP1 receptor coagonists: survodutide GIP/GLP1/glucagon receptor triple coagonists: retatrutide Obesity is a disease that can be treated with targeted pharmacotherapy in addition to lifestyle modification and behavioral interventions
Glucagon-like peptide-1 (GLP-1) receptor agonistssometimes called incretin mimeticsare a class of medications shown to be effective in managing type 2 diabetes as well as in treating individuals with obesity or overweight
